Clinical Trial

A Study to Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLC

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to compare the efficacy similarities between QL2107 and Keytruda in metastatic non-squamous NSCLC.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-23.
Status change: Not Yet Recruiting → Recruiting 2025-06-05
Trial Details
NCT Number NCT06754644
Lead Sponsor Qilu Pharmaceutical Co., Ltd.
Conditions NSCLC
Enrollment 808 participants
Start Date 2025-01-15
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-06-10